aboutus
Home > About Us>

Teaminfo

REAGEN LLC

REAGEN LLC REAGEN LLC REAGEN LLC REAGEN LLC
1 2 3 4
REAGEN LLC
<-Video Images->
Business Type: Manufacturer
Main Market: North America
South America
Western Europe
Eastern Europe
Southeast Asia
Africa
Brands: REAGEN
No. of Employees: 50~80
Annual Sales: 15000000-20000000
Year Established: 2012
Export p.c: 70% - 80%
email: reagenkits@gmail.com
About Us

Introduction

History

Our Team
Introduction

Here REAGEN LLC, focus on manufacturing ELISA kits including clinical disease detecting kits, food&feed safety test kits and animal epidemic virus detecting kits in US for 8 years.Our core products are Chloramphenicol（CAP），Gentamicin(GM)，Furazolidone(AOZ)，Nitrofurazone(SEM)，Kanamycin，Sulfonamides，Aflatoxin M1，Aflatoxin B1，Testosterone，Florfenicol and BTS Combo Strip Test Kit.

China REAGEN LLC company profile 0

Food In Test kit:

Vitamin B12,Vitamin B7,Vitamin B9,L-Carnitine,Nitrate/Nitrite,Thiocyanate

Algal Toxin Test Kit: Tetrodotoxin ELISA Kit,TTX strip test

Insecticide Test Kit: Carbendazim

Experimental Instrument:

Microplate reader,Microplate washer,Centrifuge,pipette,HealForceReal-TimePCR

Advantages of enterprise cooperation

1.Exclusive agency can be authorized.

2.Flexible pricing system.


Advantages of elisa kit

1.High recovery rapid, and cost-effective extraction methods

2.High sensitivity and low detection limit

3.High reproducibility

4.Strong specificity

5.High accuracy

6.The pretreatment method is diverse, flexible and convenient.

 

selling point of elisa kit

2.provide the free samples and technical support of 24 hours.

 

History

2012—— In terms of technological innovation, the company has always attached importance to the building of technological innovation capability and the construction of product echelons. The company now has a provincial technology accreditation technology center, under the jurisdiction of the three laboratories of preparation, synthesis and biology.
2012—— The company now has nearly 17 new drugs, three new drugs and two new drugs, and 1 new drugs with independent intellectual property rights.
2016—— The company has maintained good cooperation with many other scientific research institutions. The annual cost of technology R & D is up to 5% of the sales revenue.
2016—— The company has implemented a two wheel drive strategy in marketing, and has always adhered to the business mode of the overseas middle end market and the domestic middle and low end market.
2018—— The company aims at building a harmonious enterprise and persists in putting people first and always safeguarding the rights and interests of workers. The three party committee was awarded the title of "model enterprise of provincial harmonious labor relations" by the Provincial Committee on coordinated labor relations, and was named "the advanced collective of the city wage consultation contract" by the general trade union of the city.

Our Team

  • We have a professional technicians  and sales team

Contact Details